Neil Veloso is the most senior officer in the University focused on commercializing Brown innovations through new venture creation, industry collaborations and licensing with strategic partners. Neil has spent two decades at the intersection of academic research, healthcare and commercialization. As a consultant and advisor, he worked with leading academic medical centers and institutions, private and public universities, and investors. Neil has held senior roles in commercialization as the Executive Director of technology transfer at Johns Hopkins University and a Senior Director at Cleveland Clinic Innovations. He has transactional experience in the fields of therapeutics, information technology, engineering and diagnostics with both established companies and venture-backed startups. Contact Neil if you are interested in partnering with industry to explore commercial pathways for your research.
Brian Demers is an executive leader with proven results in developing and managing new business and technology ventures. Early in his career, Brian co-founded and was Vice President of Engineering at ViaDSP. After the company was acquired by NMS Communications, Brian stayed on in various roles including VP & General Manager of the Mobile Application business unit (subsequently spun out as Livewire Mobile). A Brown alum, Brian joined IECV in 2012. Contact Brian for support with commercial venturing inquiries regarding engineering and physics.
Len Katzman, JD
Director of Business Development- Data and Computer Science
(401) 863-9896 | Email
As an attorney and business development professional, Len fosters strategic collaborations with industry through licensing, sponsored research, and launching new ventures. Prior to joining Brown in 2007, Len was a business attorney concentrating on intellectual property law, technology transactions, business contract negotiations, corporate governance and business counsel. Len’s work is informed by a 15-year career in private industry as a software engineer and computer systems development professional in businesses ranging from startups to Fortune 100 companies. Len has a B.S. in Computer Science from the University of Rhode Island and a J.D., cum laude, from Rogers Williams University School of Law. Contact Len for support with commercial venturing inquiries regarding data and computing science or questions about intellectual property.
David Potter, MBA
Director of Business Development- Life Sciences
(401) 439-7711 | Email
Dave has led the commercialization of innovative healthcare and life science ventures for more than twenty years. As both a founding entrepreneur of successful start-ups (Previser Inc., Pro-Change Systems Inc, etc.) and as the business partner of leading labs from multiple universities, he has developed an ecosystem of collaborative development resources and funding vehicles to accelerate intellectual property development, and to access well-aligned commercial partners and customers. Dave is a graduate of Bowdoin College and has an MBA from the Amos Tuck School at Dartmouth. Contact Dave if you are interested in commercial venturing or partnering with industry around opportunities in the life sciences.
Betsy Stubblefield Loucks, '99, ScM, MBA
Research Partnerships Manager
(401) 580-8075 | Email
For the past twenty years, Betsy has been a strategist, communicator and facilitator for social ventures, non-profits, academic and government agencies that address public health, housing, and environmental sustainability. A Brown alum, she also has a Masters of Science in Social Epidemiology from the Harvard School of Public Health and an MBA in small business and sustainability from Concordia University (Montreal, QC). Contact Betsy if you are interested in cross-departmental collaborations on commercial opportunities or university-industry partnerships.
Karen Bulock, PhD
Managing Director, Brown Biomedical Innovations-To-Impact Fund
(401) 863-5460 | Email
Karen has over twenty years of experience in discovery, preclinical, and early stage clinical project management. Prior to coming to Brown in August 2018, she served as Vice President of Research at RXi Pharmaceuticals Corporation and as Associate Director of Research at Galena Biopharma, Inc. Karen has a PhD in Pharmacology from Yale University. Contact Karen for information about BBII awards to fund biomedical translational research projects and for support with translational research and commercialization of biomedical technologies.
(401) 863-1990 | Email
A graduate of Rhode Island College, Jenn has been an Intellectual Property Paralegal for over 10 years. Prior to joining Brown, she worked as the Senior Intellectual Property Paralegal for MIT’s tech transfer office. Her “in the trenches” experience includes managing the administrative aspects of patent prosecution, maintaining data integrity of the patent management database and supporting the work of licensing officers with patent portfolio management in order to ensure the appropriate protection of intellectual property assets. Contact Jenn with any questions related to submitting an invention disclosure, application status and department billing.
The IECV Team works closely with Adler, Pollack and Sheehan regarding intellectual property management. Daniel Holmander of APS manages the contract with Brown. Daniel is a U.S. Patent and Trademark Office registered patent attorney (U.S. Reg. No. 59,518) and admitted to the federal district courts in Rhode Island and Massachusetts. Most importantly, Daniel has extensive experience in developing and executing strategies for clients’ intellectual property portfolios with a sharply honed focus on furthering their business objectives. As a registered patent attorney with the United States Patent and Trademark Office, Daniel advocates for and counsels clients in intellectual property areas such as patents, trademarks, copyrights, trade secrets, unfair competition, and domain names. Daniel’s range of technology areas includes medical technologies, software, biofuels, nanotechnology, material science, eyewear, coatings, vaccines, chemicals, consumer packaging, biotechnology, and green technologies. In addition to his law practice, Daniel is an adjunct Professor of Molecular Pharmacology, Physiology, and Biotechnology at Brown University.